Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/24385120
其他信息:
PMID: 24385120
作者: Angela Moore; Steven Kempers; George Murakawa; Jonathan Weiss; Amanda Tauscher; ...
摘要: Once-daily topical brimonidine tartrate (BT) gel 0.5% was shown to be efficacious and safe for the treatment of erythema of rosacea in previous studies including a 4-week treatment phase. In the present 1-year study, we aimed to assess the long-term safety and efficacy of the treatment. Subjects with moderate to severe erythema of rosacea were instructed to apply topical BT gel 0.5% once daily for 12 months. Severity of erythema and adverse events (AEs) were evaluated. Approximately 345 subject ...
